Joseph Vazzano
2021 - AVENUE THERAPEUTICS
In 2021, Joseph Vazzano earned a total compensation of $441.3K as Chief Financial Officer at AVENUE THERAPEUTICS, a 105% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $80,513 |
|---|---|
| Salary | $255,747 |
| Stock Awards | $93,470 |
| Other | $11,600 |
| Total | $441,330 |
Vazzano received $255.7K in salary, accounting for 58% of the total pay in 2021.
Vazzano also received $80.5K in non-equity incentive plan, $93.5K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Joseph Vazzano's compensation ranked 10,980th out of 12,406 executives tracked by ExecPay. In other words, Vazzano earned more than 11.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,980 out of 12,406 | 12th |
Division Manufacturing | 4,840 out of 5,492 | 12th |
Major group Chemicals And Allied Products | 2,162 out of 2,368 | 9th |
Industry group Drugs | 1,923 out of 2,089 | 8th |
Industry Pharmaceutical Preparations | 1,420 out of 1,536 | 8th |
Source: SEC filing on November 18, 2022.
Vazzano's colleagues
We found one more compensation record of an executive who worked with Joseph Vazzano at AVENUE THERAPEUTICS in 2021.
2021
Lucy Lu
AVENUE THERAPEUTICS
Chief Executive Officer
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019